• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Derm division













































































Why don't you go ask Van Manier, the answer is YES at a POA and HR did nothing! how sad is that? I received a call along with many others, that is how sad this place is. So maybe all of you will one day realize this place is filled with such aholes!